Sodium/glucose cotransporter: Difference between revisions
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
The drug Dapagliflozin contains a <scene name='10/1042600/Cv/5'>glucose moiety which stacks against residue Y290</scene> of SGLT2. The <scene name='10/1042600/Cv/6'>glucose moiety forms multiple H-bonds</scene> to SGLT2<ref>PMID:38057552</ref>. Water molecule is shown as red sphere. | The drug Dapagliflozin contains a <scene name='10/1042600/Cv/5'>glucose moiety which stacks against residue Y290</scene> of SGLT2. The <scene name='10/1042600/Cv/6'>glucose moiety forms multiple H-bonds</scene> to SGLT2<ref>PMID:38057552</ref>. Water molecule is shown as red sphere. | ||
See also: | |||
*[[Canagliflozin]] | |||
*[[Dapagliflozin]] | |||
*[[Empagliflozin]] | |||
==3D structures of sodium/glucose cotransporter== | ==3D structures of sodium/glucose cotransporter== | ||